Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TERLIPRESSIN-AFT SOLUTION FOR INJECTION 0.85MG/8.5ML

Approval Number

SIN17190P

Drug Name

TERLIPRESSIN-AFT SOLUTION FOR INJECTION 0.85MG/8.5ML

Product Name

TERLIPRESSIN-AFT SOLUTION FOR INJECTION 0.85MG/8.5ML

Approval Date

February 28, 2025

Registrant

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

H01BA04

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

HAINAN POLY PHARM. CO., LTD.

Active Ingredients

Ingredient Name

TERLIPRESSIN

Strength

0.85mg/8.5ml

Drug MonographTerlipressin

Documents

Package Inserts

Terlipressin-AFT Solution for Injection PI.pdf

Approved: February 28, 2025

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy